ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,253,000 | +2.2% | 19,681 | -0.9% | 0.04% | -11.6% |
| Q4 2014 | $1,226,000 | +123.3% | 19,866 | +40.6% | 0.04% | +115.0% |
| Q3 2014 | $549,000 | +12.7% | 14,127 | -0.1% | 0.02% | +11.1% |
| Q2 2014 | $487,000 | -20.3% | 14,140 | +0.1% | 0.02% | -28.0% |
| Q1 2014 | $611,000 | – | 14,122 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |